Allogeneic Cell Therapy: The Treatment of Choice for All Hematologic Malignancies Relapsing Post BMT [Letter; Comment]
Blood - United States
doi 10.1182/blood.v87.9.4011.bloodjournal8794011
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 1996
Authors
Publisher
American Society of Hematology